Tao Yue

Title: The Innovations of Tao Yue

Introduction

Tao Yue is an accomplished inventor based in Coppell, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic compositions.

Latest Patents

Tao Yue holds a patent for an "Activatable IL2 composition and methods of use." This invention includes proteins, nucleic acids, and methods for creating and utilizing an activatable interleukin-2 (aIL2). The composition comprises an Interleukin-2 (IL2) fusion protein that includes a wild-type or mutein IL2, a first cleavable linker, an interleukin-2 receptor binding region (IL2RB), and a half-life extender, such as an antibody Fc region. The unique feature of this invention is that the cleavage of the cleavable linker releases the IL2 from the interleukin-2 receptor beta binding region.

Career Highlights

Tao Yue is currently associated with Immune Targeting, Inc., where he continues to advance his research and development efforts. His work focuses on enhancing the efficacy of interleukin-2 therapies, which are crucial in immunotherapy.

Collaborations

Tao Yue collaborates with Yang Wang, contributing to the innovative projects at Immune Targeting, Inc. Their combined expertise fosters a productive environment for groundbreaking research.

Conclusion

Tao Yue's contributions to biotechnology, particularly through his patent on activatable IL2 compositions, highlight his role as a significant inventor in the field. His ongoing work at Immune Targeting, Inc. promises to lead to further advancements in therapeutic applications.